Biocom’s top priority is the safety of our members and the well-being of our employees. After careful consideration, Biocom has decided to transform our 2021 Global Life Science Partnering Conference to a fully virtual event. We know that many lives are being impacted and disrupted by COVID-19 and we are grateful to be able to continue offering our members valuable content in a safe manner.
President, Merck Research Labs Ventures Fund
Rez currently serves as President of MRL Ventures Fund, the global corporate venture arm of Merck research. Previously, he led Merck’s business development and licensing activities in Europe. He has also held management roles in large Pharma, private life-science companies and academia. He has served as a board member on numerous early and clinical stage companies. Rez received his B.Sc. and Ph.D. from Newcastle University, UK.